Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06945640Not ApplicableEnrolling By Invitation

Evaluation of 'RUS NE' in Robot-Assisted Partial Nephrectomy: Efficacy, Safety, and Stability

Role: lead

NCT06868186Not ApplicableRecruiting

A Multicenter Study of RUS NE

Role: lead

NCT06952894Not ApplicableCompleted

Feasibility of RUS Lung in MITS

Role: lead

NCT05039333Unknown

Clinical Study to Prove Safety and Effectiveness When Applying RUS™ Surgical Navigation

Role: lead

All 4 trials loaded